Vertex stock rises as non-opioid pain drug shows positive results in pivotal trials
Daniel Grizelj Vertex Pharmaceuticals (NASDAQ:VRTX) is trading around +6.5% premarket on Tuesday after it reported positive results from a Phase…
Daniel Grizelj Vertex Pharmaceuticals (NASDAQ:VRTX) is trading around +6.5% premarket on Tuesday after it reported positive results from a Phase…